Reinsurance Group of America, Incorporated (NYSE:RGA) is a leading global provider of traditional life and health reinsurance, as well as financial solutions. The company operates in various markets worldwide, offering a diverse range of products that cater to the needs of its clients. RGA competes with other major players in the reinsurance industry, such as Swiss Re and Munich Re.
The consensus price target for RGA has shown a positive trend over the past year. Last month, the average price target was $237.50, indicating a positive outlook from analysts. This aligns with Wells Fargo's price target of $238, as highlighted by Zacks, suggesting potential upside for the stock. Analysts expect RGA to perform well in the near term.
Three months ago, the average price target was $228.25, showing an increase of $9.25 compared to the last quarter. This suggests growing confidence among analysts in RGA's performance. The Zacks Rank system, which focuses on earnings estimates and revisions, also highlights RGA as a promising stock, despite not having the optimal combination of factors for an earnings beat.
A year ago, the average price target was $219.63, representing a significant increase of $17.87 over the year. This strong upward trend in analyst expectations reflects positive sentiment regarding RGA's potential for growth. The company's global presence and diverse product offerings likely contribute to this optimistic outlook.
RGA is anticipated to experience earnings growth, although it may not achieve an earnings beat in its upcoming report. The company will release its fourth-quarter earnings on February 5, followed by a conference call on February 6. Investors are advised to understand key expectations surrounding RGA's performance, as highlighted by Zacks.
